Treatment of Local Anesthetic-Induced Cardiotoxicity Using Drug Scavenging Nanoparticles
Nano Letters2004Vol. 4(4), pp. 757–759
Citations Over TimeTop 10% of 2004 papers
Abstract
Because of its ability to create structures of nanoscale dimension with large aggregate particle surface area-to-volume ratios, nanotechnology offers new opportunities to treat drug poisonings. Emulsion-based nanoparticles (diameter: 118.4 nm) extracted bupivacaine from the aqueous phase in a physiological salt solution and attenuated the drug's cardiotoxicity in guinea pig heart to a greater extent than did a macroemulsion (432.0 nm). Additionally, nanoparticles sequestered bupivacaine from the aqueous phase of human blood and merit further investigation in animal models of intoxication.
Related Papers
- → Preparation of oil-in-water and water-in-oil emulsions with the same composition using hydrophilic nanoparticles by three-phase emulsification(2023)6 cited
- → Bupivacaine Suppresses [Ca2+]i Oscillations in Neonatal Rat Cardiomyocytes with Increased Extracellular K+ and Is Reversed with Increased Extracellular Mg2+(2000)12 cited
- → The Influence of Age on Bupivacaine Cardiotoxicity(2011)12 cited
- → Unwarranted concern over use of rac-bupivacaine for cutaneous operation(2003)1 cited
- → Mechanism of myocardial toxicity induced by bupivacaine(2016)